Ionis Pharmaceuticals Inc (IONS) P/S ratio history

$42.93

Latest weekly close · Market cap $7.1B

Share IONS P/S history
Within its usual range

As of

IONS's P/S of 8.1x is lower than 52% of its weekly readings over the last five years.

Weekly P/S with its 5-year range

P/S each weekMiddle half of the last 5 years5-year median 8.2×
P/S weekly history0×5×10×15×8.1×20222023202420252026
5-year median
8.2×
10-year median
9.4×
5-year low to high
5.6×–14.3×
Versus 5-year median
-1%

P/S

48thpercentile

of its weekly readings over the last five years

Within its usual range

Growth, last 12 months vs the year before

Revenue
-7%slowing
EPS
n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading
010020030020222023202420252026

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

IONS P/S at each year-end
Year-endP/S5-year percentile
13.2×97
6.4×10
11.8×86
6.1×3
6.5×2
8.5×16
10.6×11
13.4×39
12.6×3
24.8×74

Loading peers and related research…

About this history

What is IONS's current P/S?
IONS's P/S of 8.1x is lower than 52% of its weekly readings over the last five years.
What is IONS's five-year median P/S?
8.2x. Half of IONS's weekly readings over the last five years were higher and half were lower. This page has 808 weekly readings, from May 2, 2011 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares IONS only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built